5OS-derived cores were prepared by treatment of 50S subunits with 0.4 M LiCI (0.4c core) and 0.8 M LiCI (0.8c core), respectively. 0.4c cores bind chloramphenicol whereas 0.8c cores Chloramphenicol, a well-known inhibitor of protein synthesis in prokaryotic cells, binds to ribosomes (1). In vitro (2, 3) and in vivo (4, 5), the binding occurs in a 1:1 stoichiometry. Only the large ribosomal subunit (50 S) is involved (6).
Chloramphenicol, a well-known inhibitor of protein synthesis in prokaryotic cells, binds to ribosomes (1) . In vitro (2, 3) and in vivo (4, 5) , the binding occurs in a 1:1 stoichiometry. Only the large ribosomal subunit (50 S) is involved (6) .
The drug action is related to peptide-bond formation. This is demonstrated by chloramphenicol inhibition of the "fragment reaction" (7) , which is a model reaction for peptide-bond formation. The fragment reaction uses 50S subunits, a peptidyl-tRNA fragment [CACCA-(N-acetyl-leucyl) ], puromycin as an analogue of an aminoacyl-tRNA fragment, K+ and Mg++ ions, and the unusual requirement of 33% alcohol. Although evidence has accumulated that chloramphenicol inhibits the binding of the aminoacyl terminus of the aminoacyl-tRNA (8) (9) (10) (11) (12) , interference with the peptidyl recognition center of the peptidyltransferase has been considered (13) (14) (15) (16) .
In min, and the aggregated ribosomes were pelleted at 7000 X g for 5 min. 100 Ml of the supernatant or from the control assay (without ribosomes) were mixed with 0.5 ml of Soluene before addition of 5 ml of scintillation fluid. The amount of bound substrate was calculated by the difference between the assay containing ribosomes and the control assay.
Other Methods. Cores and split proteins from the 50S subunit were prepared, and partial reconstitution and the fragment assay were performed as described elsewhere (K. H. Nierhaus and V. Montejo, manuscript in preparation).
The EF-G-dependent GTPase test followed the method described by Parmeggiani (20) .
RESULTS
Identification of the protein involved in chloramphenicol binding The relative concentrations of the proteins L6, Lli, and L16 in the particles (0.8c + fraction 39) and (0.8c + fraction 43) were estimated from the 2-dimensional electrophoresis pattern (Fig. 2) .
for chloramphenicol binding, and their protein patterns were displayed by 2-dimensional electrophoresis ( Fig. 2 and Table  2 ). L6 is present only in (0.8c + fraction 39) and not in (0.8c + fraction 43), whereas L16 is found in (0.8c + fraction 39) in traces and in (0.8c + fraction 43) in much greater amounts. L1i is present in both particles in about the same amount. In the chloramphenicol binding test, (0.8c + fraction 43) bound more than twice the amount of chloramphenicol bound by (0.8c + fraction 39) ( Table 2 ). The binding by the two particles was correlated to the amount of L16 (Table 2) . From another preparation of cores and split proteins, we prepared a particle containing L6 and L11 but not L16. This particle had the same background binding as the 0.8c core. Therefore, it can be concluded that L16 is responsible for the chloramphenicol binding.
Characterization of the chloramphenicol binding A Scatchard plot (Fig. 3) of the data for chloramphenicol binding revealed one binding site for chloramphenicol (KA = 9.0 X 106 M-1). Table 3 demonstrates that 0.8c core binds the CACCA-(AcLeu) fragment nearly as well as the 50S subunit. Therefore the 0.8c core contains the intact p-site part of the peptidyltransferase center. On the other hand, the 0.8c core does not Incubation of particles and the fragment was performed in the presence of 50% ethanol at 40 for 10 min. After the particles were pelletted, an aliquot of the supernatant was removed and counted. The difference from a control without ribosomes gave the cpm of bound fragment. The method was a modification of Celma et al. (19) .
bind chloramphenicol. Thus, chloramphenicol does not act on the p-site part of the peptidyltransferase center.
As chloramphenicol inhibits binding of aminoacyl oligonucleotides (for example CCA-Phe) to ribosomes (8, 10), we checked a mixture of 20 amino acids and oligonucleotides for inhibition of chloramphenicol binding to ribosomes. As is Fig 1) . The (0.8c + fraction 39) particle bound 0.07 pM and the (0.8c + fraction 43) particle bound 0.18 pM chloramphenicol per pM particle. seen in Fig. 4 , a mixture of 20 amino acids does not inhibit even with the highest concentration tested (20 mM). In contrast, puromycin as an analogue of an aminoacyl oligonucleotide inhibits chloramphenicol binding. About 85% inhibition is seen with 40 mM puromycin. At least up to a concentration of 20 mM the trinucleotide CpCpA inhibited the chloramphenicol binding nearly to the same extent as puromycin did. At 20 mM CpA shows a slight but significant inhibition, whereas ApC and UpU have no effect (Table 4) .
As chloramphenicol acts mainly on the a-site part of the peptidyltransferase center and the EF-G-dependent GTPase center seems to be located in the a-site (ref. 21 ; R. Werner, K. Bordasch, and K. H. Nierhaus, manuscript in preparation), an interaction of chloramphenicol and this GTPase activity could be possible. However, chloramphenicol in concentrations up to 25 mM did not significantly alter the EF-Gdependent GTPase activity (Table 5 ).
DISCUSSION
Chloramphenicol inhibits the fragment reaction (7). This reaction can be divided into three steps, as pointed out by Pestka (8): (a) binding of the peptidyl-tRNA fragment to the p-site part of the peptidyltransferase center, (b) binding of the analogue (puromycin) of an aminoacyl-tRNA fragment to the a-site, and (c) the covalent linkage of the peptidyl residue to puromycin (peptidyltransferase reaction). There is no doubt that chloramphenicol acts at least on the a-site moiety for the following reasons:
(1) A phenylalanyl-tRNA fragment (CACCA-Phe) binds°2 to the a-site of 70S ribosomes since this binding occurs at a puromycin-insensitive site (i.e., phenylalanyl-puromycin formation does not take place, which is the definition of the a-site) and can be inhibited by puromycin, i.e., puromycin binds to the same or an overlapping site (8) . Chloramphenicol inhibits this fragment binding (8) .
(2) If chloramphenicol and puromycin both inhibit CA-CCA-Phe binding, chloramphenicol should inhibit puromycin binding and vice versa. In fact a partial inhibition of chloramphenicol binding by puromycin has been described (11, 12) . Furthermore, Fig. 4 demonstrates that puromycin can completely inhibit chloramphenicol binding. Thus, chloramphenicol and puromycin seem to compete for the same site.
This conclusion has been confirmed by Celma et al. (10) who demonstrated a complete inhibition of UACCA-Leu binding under fragment reaction conditions by a chloramphenicol concentration sufficient to give nearly complete inhibition of the fragment reaction, whereas under the same conditions the CACCA-(AcLeu) binding was not affected. CACCA-(AcLeu) most probably binds to the p-site. Thus, it is evident that chloramphenicol does not interact with the p-site of the peptidyltransferase center. This is confirmed by the binding studies with the 0.8c core. Table 3 shows that the CACCA-(AcLeu) fragment is bound to the 0.8c core to the same extent as to the 50S subunit, i.e., the 0.8c core contains the intact p-site part of the peptidyltransferase center. However, 0.8c core does not bind chloramphenicol (Table 1, Exp. 2). This result shows that chloramphenicol does not bind to the p-site part of the peptidyltransferase center. Therefore, the chloramphenicol binding site belongs exclusively to the a-site part of the peptidyltransferase center.
The minimal structure of aminoacyl-tRNA that can bind to the a-site part at the peptidyltransferase center consists of the 3'-terminal CpA and the aminoacyl residue (22, 23) . Therefore we tested the interference of appropriate oligonucleotides (CpCpA, CpA, and as a control, ApC and UpU) and of an amino-acid mixture with chloramphenicol binding (Fig. 4 and Table 4 ). CpCpA inhibited the chloramphenicol binding as effectively as puromycin at least up to a concentration of 20 mM; CpA showed a slight inhibition, and ApC, UpU, and the amino-acid mixture showed no inhibition. We conclude that chloramphenicol interferes with the binding of the last two or three nucleotides (3' end) of aminoacyl-tRNA. In contrast to the strong inhibition of binding of aminoacyl oligonucleotides by chloramphenicol, the drug only slightly affects aminoacyl-tRNA binding to the a-site (24, 25) . Thus, (Fig. 3) . The plot for 70S ribosomes is similar to the data for the 50S subunits with n = 1.2 binding sites per 70S ribosome and the association constant KA = 1 X 106 (M -1) (unpublished observation). Our data do not confirm the finding of Lessard and Pestka (12) who postulated a second binding site-a low affinity site-for chloramphenicol. We found with high chloramphenicol concentration (0.25-1 mM) several points with n = 2 up to n = 11, which can be expected by unspecific binding with low affinity (Fig. 3 ).
An analysis of the chloramphenicol-binding site was carried out with 5OS-derived cores and fractionated split proteins. Reconstitution studies with 0.8c cores (20) .
